Advertisement

Topics

"Mangafodipir as an Adjunct to Percutaneous Coronary Intervention" Drugs and Medication Database

10:12 EST 16th February 2019 | BioPortfolio

Here are the most relevant "Mangafodipir as an Adjunct to Percutaneous Coronary Intervention" Drugs and Medications that we have found in our database.

More Information about "Mangafodipir as an Adjunct to Percutaneous Coronary Intervention" on BioPortfolio

We have published hundreds of Mangafodipir as an Adjunct to Percutaneous Coronary Intervention news stories on BioPortfolio along with dozens of Mangafodipir as an Adjunct to Percutaneous Coronary Intervention Clinical Trials and PubMed Articles about Mangafodipir as an Adjunct to Percutaneous Coronary Intervention for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mangafodipir as an Adjunct to Percutaneous Coronary Intervention Companies in our database. You can also find out about relevant Mangafodipir as an Adjunct to Percutaneous Coronary Intervention Drugs and Medications on this site too.

Showing "Mangafodipir Adjunct Percutaneous Coronary Intervention" Drugs and Medications 1–25 of 572

Probably Relevant

Eptifibatide [akorn, inc.]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION, safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION.EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [aurobindo pharma limited]

These highlights do not include all the information needed to use eptifibatide injection safely and effectively. See full prescribing information for eptifibatide injection. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Eptifibatide [auromedics pharma llc]

These highlights do not include all the information needed to use eptifibatide injection safely and effectively. See full prescribing information for eptifibatide injection. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [sagent pharmaceuticals]

These highlights do not include all the information needed to use EPTIFIBATIDE injection safely and effectively. See full prescribing information for EPTIFIBATIDE injection. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Eptifibatide [teva parenteral medicines, inc.]

These highlights do not include all the information needed to use eptifibatide injection safely and effectively. See full prescribing information for eptifibatide injection. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Eptifibatide [mylan institutional llc]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998

Possibly Relevant

Effient [eli lilly and company ]

These highlights do not include all the information needed to use EFFIENT safely and effectively. See full prescribing information for EFFIENT. EFFIENT (prasugrel) tablets, for oral use Initial U.S. Approval: 2009

Kengreal [the medicines company]

These highlights do not include all the information needed to use KENGREAL safely and effectively. See full prescribing information for KENGREAL. KENGREAL( c angrelor) for injection, for intravenous use Initial U.S. Approval: 201 5

Kengreal [chiesi usa, inc.]

These highlights do not include all the information needed to use KENGREAL safely and effectively. See full prescribing information for KENGREAL. KENGREAL( c angrelor) for injection, for intravenous use Initial U.S. Approval: 201 5

Prasugrel [ascend laboratories, llc]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS.PRASUGREL tablets, for oral useInitial U.S. Approval: 2009

Prasugrel [aurobindo pharma limited]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral use Initial U.S. Approval: 2009

Prasugrel [accord healthcare inc.]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral use Initial U.S. Approval: 2009

Prasugrel [apotex corp.]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral useInitial U.S. Approval: 2009

Prasugrel [panacea biotec ltd.]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral useInitial U.S. Approval: 2009

Eptifibatide [accord healthcare inc.]

These highlights do not include all the information needed to use Eptifibatide Injection safely and effectively. See full prescribing information for Eptifibatide Injection. EPTIFIBATIDE injection, for intravenous use Initial U.S. Approval: 1998

Integrilin [merck sharp & dohme corp.]

These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998

Integrilin [merck sharp & dohme corp.]

These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998

Integrilin [merck sharp & dohme corp.]

These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998

Bivalirudin [sandoz]

These highlights do not include all the information needed to use Bivalirudin safely and effectively. See full prescribing information for Bivalirudin. Bivalirudin for injection, for intravenous use Initial U.S. Approval: 2000

Angiomax [the medicines company]

These highlights do not include all the information needed to use Angiomax safely and effectively. See full prescribing information for Angiomax. ANGIOMAX (bivalirudin) for injection, for intravenous use Initial U.S. Approval: 2000

Bivalirudin [sandoz]

These highlights do not include all the information needed to use Bivalirudin safely and effectively. See full prescribing information for Bivalirudin. Bivalirudin for injection, for intravenous use Initial U.S. Approval: 2000

Lovenox [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use Lovenox safely and effectively. See full prescribing information for Lovenox. Lovenox (enoxaparin sodium injection), for subcutaneous and intravenous use Initial U.S. Approval: 1993

Lovenox [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use Lovenox safely and effectively. See full prescribing information for Lovenox. Lovenox (enoxaparin sodium injection), for subcutaneous and intravenous use Initial U.S. Approval: 1993

Enoxaparin sodium [winthrop u.s.]

These highlights do not include all the information needed to use Enoxaparin sodium injection safely and effectively. See full prescribing information for Enoxaparin sodium injection. Enoxaparin sodium injection, for subcutaneous and intravenous use Initi



Advertisement
Quick Search
Advertisement
Advertisement